TMCnet News
Registration Opens for Access Insights Conference 2024 Co-Hosted by IntegriChain and Blue Fin GroupIndustry Conference Focused on Strategies to Drive Access and Commercialization in Era of Net Revenue Optimization Features Keynote Bill Roth, Industry Expert Panels, and ICyte Platform Updates PHILADELPHIA, April 9, 2024 /PRNewswire/ -- IntegriChain, delivering pharma's only comprehensive technology, data, consulting, and outsourcing platform for data-driven commercialization, today announced that registration is now open to all pharma manufacturers for the Access Insights Conference 2024, co-hosted with Blue Fin Group. The Access Insights Conference will be held October 14-16, 2024, at The Mayflower Hotel, Autograph Collection, in Washington, DC. Designed for commercial, operational, and financial teams at pharma manufacturers, the conference will feature industry panels, healthcare policy and financial experts, and strategic and tactical best practices for data-driven patient access and therapy commercialization. Keynoting the conference will be Bill Roth, General Manager and Managing Partner of Blue Fin Group and a recognized expert on business model development in healthcare. Roth will explore how chief commercial officers and access leaders can plan for success while navigating new regulatory, contracting, and distribution impacts. Details and registration for the conference can be found here. "As the Pharma industry continues to generate ground-breaking new product innovation, it must navigate significant regulatory, pricing, and financial challenges," said IntegriChain Chief Executive Officer Josh Halpern. "Our conference taps into the collective brainpower of industry and healthcare policy experts to explore current trends and deliver data-driven strategies and tactics for commercialization, contracting and reimbursement, net revenue forecasting, and channel management success in oday's climate. We are excited to co-host this year's conference again with our esteemed colleagues from Blue Fin Group, and together we will deliver high-value information and insights to our attendees who are commercializing important innovative therapies." About the Access Insights Conference Executive Summit Hot Topics Contracts, Pricing, and Reimbursement: the continuing impact of the Inflation Reduction Act and Medicare price negotiations, Part D benefit redesign, WAC price reductions and dual pricing strategies, 340B Program controls and dispute intelligence, and transforming access through data and technology Channel Strategy and Patient Journey: deep dives into balancing patient services and net revenue optimization, maximizing longitudinal patient data, DSA management from all perspectives, and the latest on serialization Net Revenue Forecasting and Planning: insights on best practices in forecasting, examining stakeholder economics from all sides, the impact of copay accumulators, and gross-to-net over the entire product lifecycle New Archetype Commercialization: expertise and insights on biosims and specialty generics, contracting for HCP-administered drugs, and launching cell and gene products Eyes on ICyte About Blue Fin Group, an IntegriChain Company About IntegriChain Contact View original content to download multimedia:https://www.prnewswire.com/news-releases/registration-opens-for-access-insights-conference-2024-co-hosted-by-integrichain-and-blue-fin-group-302111156.html SOURCE IntegriChain |